Sedative agents in the management of severe traumatic brain injury: from pathophysiological rationale to clinical practice
Frontiers in Pharmacology · 17.11.2026 · 17
DOI: 10.3389/fphar.2026.1999184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.11.2026. Verfasst von Xiaoyu Yang und 4 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Severe traumatic brain injury (sTBI) represents a leading cause of trauma-related mortality and long-term disability worldwide, with raised intracranial pressure (ICP) and secondary brain injury constituting the primary drivers of poor prognosis. Sedation serves as a cornerstone of sTBI management by mitigating stress responses, reducing cerebral metabolic demand, and facilitating ICP control, yet its clinical application remains complicated by heterogeneous drug pharmacokinetics, dynamic neurophysiological goals, and limited high-quality evidence guiding agent selection. While short-acting agents such as propofol and remifentanil are favored for their titratability and rapid offset, controversies persist regarding optimal sedation depth, duration, and the balance between neuroprotection and oversedation-related complications. In this review, we synthesize current evidence on the pathophysiology underpinning sedation use in sTBI, evaluate the pharmacological profiles of commonly employed sedatives—including volatile anesthetics, intravenous hypnotics, and analgesics—and discuss emerging strategies for personalized sedation management guided by multimodal neuromonitoring. We further highlight critical knowledge gaps and propose directions for future translational research to refine sedation protocols and improve functional outcomes in sTBI populations.
Zitieren
APA
Yang, X., Sun, T., Zhang, Y., Guan, J., & Ren, Y. (2026). Sedative agents in the management of severe traumatic brain injury: from pathophysiological rationale to clinical practice. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1999184
Vancouver
Yang X, Sun T, Zhang Y, Guan J, Ren Y. Sedative agents in the management of severe traumatic brain injury: from pathophysiological rationale to clinical practice. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1999184
BibTeX
@article{Yang2026,
author = {Yang, Xiaoyu and Sun, Tong and Zhang, Yuekang and Guan, Junwen and Ren, Yanming},
title = {Sedative agents in the management of severe traumatic brain injury: from pathophysiological rationale to clinical practice},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1999184}
}
EUVIMED